Evidence-Based Guidance for the Management of Immune-Related Adverse Events: Resources for Clinicians

Review guidance from the experts and NCCN Guidelines® on optimal management of immune-related adverse events in patients receiving checkpoint inhibitor&ndash based therapy. Gain clinical insights with an interactive module downloadable slideset short expert commentaries and an Interactive Decision Support Tool that customizes irAE management recommendations from the NCCN Guidelines® to the patient scenario you provide!

Share

Program Content

Activities

NCCN irAE Tool
An Interactive Algorithm Tool Featuring NCCN Guidelines for the Management of Immune-Related Adverse Events for Patients Receiving Immune Checkpoint Inhibitors
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 07, 2019

Managing irAEs
How I Manage Immune-Related Adverse Events in My Nursing Practice
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: March 19, 2019

Activities

irAE Management: Slides
Evidence-Based Management of Adverse Events From Cancer Immunotherapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 07, 2019

Faculty

cover img faculity

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP

Associate Professor
Coordinator of Oncology Concentration

Yale University School of Nursing
Oncology Nurse Practitioner
Medical Oncology
Smilow Cancer Hospital at Yale-New Haven
New Haven, Connecticut

cover img faculity

John A. Thompson, MD

Professor of Medicine
Division of Medical Oncology
University of Washington
Seattle, Washington

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb

EMD Serono

Pfizer, Inc.

Partners

NCCN

ProCE Banner